Cubosomes: A Potential Drug Delivery System

Authors

  • Kajal Chaudhary Assistant Professor, Department of Pharmaceutics, Babu Banarsi Das Institute of Technology, Ghaziabad, Uttar Pradesh -201001 
  • Devender Sharma Research Scholar, Department of Pharmaceutics, Lovely Institute of Technology (Pharmacy), Lovely Professional University, Punjab-144411, India

DOI:

https://doi.org/10.22270/ajprd.v9i5.981

Keywords:

Cubosomes, Cubic Phase, Mono-olein

Abstract

The discovery of cubosomes is a classic story and deals with food science, differential geometry, biological membranes and digestive processes. Cubosomes are highly balanced and nanoparticles in design formed primarily from the lipid cubic state and protected by a polymer-based outer circle. Hydrating a surfactant that designates cubic phase and then disperses a solid state into smaller particles, typically forms cubosomes. They behave concretely like rheology with unique properties of practical interest. Cubosome formation can be optimized to engineer pore size or consist of bioactive lipids, polymers can be used for targeting to the outer circle and they are highly secure under physiological conditions. This type of network structure gives them greater drug trapping potential. Related to liposomes, the structure adds a significantly more enhanced membrane surface area to trap membrane proteins and small drug entities. Cubosome may increase the solubility of poorly soluble drugs. Due to modern advances, nanoparticles patterns include drug delivery, membrane bioreactors, artificial cells and biosensors and can be engineered both in vitro. This review, focused on modern advances in cubosome technology, not only facilitates their work but also contributes to standard procedures for the rational design of innovative systems for biomedical applications. Due to the nature of cubosome dispersion being bio-adhesive and biocompatible, as well as having different properties, cubosomes are functional systems, administered in a variety of ways, such as orally and parenterally. Cubosome structure is investigated through electron microscopy, light scattering, X-rays, and NMR, although some researchers are studying the potential of cubosomes as a delivery system.

 

Downloads

Download data is not yet available.

Author Biographies

Kajal Chaudhary, Assistant Professor, Department of Pharmaceutics, Babu Banarsi Das Institute of Technology, Ghaziabad, Uttar Pradesh -201001 

Assistant Professor, Department of Pharmaceutics, Babu Banarsi Das Institute of Technology, Ghaziabad, Uttar Pradesh -201001 

Devender Sharma, Research Scholar, Department of Pharmaceutics, Lovely Institute of Technology (Pharmacy), Lovely Professional University, Punjab-144411, India

Research Scholar, Department of Pharmaceutics, Lovely Institute of Technology (Pharmacy), Lovely Professional University, Punjab-144411, India

References

1. Joshi D, Rathore S. A Review on the Bicontinuous Cubic Phase Nanoparticulate. Research and Review:Journal of Pharmacy and Pharmaceutical Sciences.2021;10(30):1-7.
2. Sri V.M, Reddy M.R . A Review on: Cubosomes Drug Delivery System. Indian Journal of Drug. 2017;5(3):104-108.
3. Esposito. Cubosomes Dispersion as Delivery System for Percutaneous Administration of Indomethacin. Pharmaceutical Research.2005;22(12):2163-2173.
4. Rao S.V, B.N Sravya . A Review on Cubosome: The Novel Drug Delivery System.GSC Biological and Pharmaceutical Sciences.2018;5(1):076-081.
5. Gaballa A.Sherif. Cubosomes: Composition, Preparation and Drug Application. Journal of Advanced Biomedical and Pharmaceutical Sciences.2020;3:1-9.
6. Mertins Omar. Ph-Sensitive Cubosomes Liquid Crystalline Nanocarriers.
7. Bansal S, Kashyap CP , Aggarwal G. A Comparative Review on Vesicular Drug Delivery System and Stability .IJRPC.2012;2:704-13.
8. Avantika Dhadwal,Vinay Pandit. Cubosomes:A Novel Carrier for Transdermal Drug Delivery, Journal of Drug Delivery and Therapeutics .2020;10(1):123-130.
9. Tilekar KB,Khade PH, Shitole MH . Cancer Oriented Cubosomes :A Review ,International Journal of Pharmaceutical Research and Scholars.2014;3:198-210.
10. Karami Z and M Hamidi,Cubosomes: Remarkable Drug Delivery potential. Drug Discovery Today .2016;21(5):789-801.
11. Jain A,Chauhan J S,et al. Cubosome: A Novel Approach for Nanotechnology. International Journal of Applied Biology and Pharmaceutical Technology .2011;2(2):19-21.
12. Thandanki M. Overview of Cubosomes:A Nanoparticle.Int J Res Pharma and Chem.2011;1:535-541.
13. Patrick T. Progress in Liquid Crystalline Dispersion: Cubosomes. Current Opinion in Colloid and Interface Sci.2005;10:274-279.
14. Patrick T. Cubosomes processing industrial nanoparticle technology development. Chem.Engineering Res.and Design.2005;83:1283-86.
15. Patond V.B.Ghonge A.B. Cubosomes-A Review. Int. Journal of Trend in Sci. Res and Development.2020;4(4).
16. Rao S. V, Sravya B.N . A Review on Cubosome: The Novel Drug Delivery System.GSC Biological and Pharmaceutical Sciences.2018;05(01):076-081.
17. Wolre G,Siekmann B. Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous manoolein/polaxmer dispersion. Eur J Pharm.Sci.2006;27:44-53.
18. Bhosale R.R,OsmaniR.A . Cuboosmes: The Inimitable Nanoparticulate Drug Carriers.Sch.Acad.J.Pharm.2013;2(6):481-486.
19. Divekar S.R,Vaidya V.R . Cubosomes -An Advanced Drug Delivery System-A Review. World Journal of Pharma.Res.2019;8(12):1570-1581.
20. Thandanki M,Kumari SP and Prabha KS: Overview of Cubosomes: A Nanoparticles, International Journal of Research in Pharmacy and Chemistry.2011;1(3):535-41.
21. Vinod K. R.Sarvya K .Tailoring Active Compound Across Biological Membranes by Cubosomal Technology. Journal of Chinese Pharmaceutical Science.2013;22(4):303-11.
22. Urvi S,Dhiren D.Overview of Cubosomes:A Nanoparticle.Int J of Pharmacy and Integrated Sci.2013;1(15):36-47.
23. Balata G, Amin M .Cubosomes :A Novel Approach for Delivery of Anticancer Drugs.American Journal of Pharmtech Research.2016;7(1):1-14.
24. Lyla P.A.Seevakan.k. Advancement of Cubosomes Nanomedicine.Int J of Pure and Applied. Mathematics.2018;119 (12):7847-7854.
25. Thomas Ancy, Raju S.P.et al. Cubosomes-A Novel Drug Delivery System.Int J of Pharmacy.2018;8 (1):10-18.
26. S Naveentaj, Y Indira Muzib. A Review on Liquid Crystalline Nanoparticles (Cubosomes): Emerging Nanoparticulate Drug Carrier. Int J Curr Pharm Res.2020;12(1):5-9.
27. Spicer PT, Small WB, Lynch ML. Dry Powder Precursor of soft Cubic Liquid Crystalline Nanoparticles(Cubosomes).Journal of Nanoparticle research.2002;4:297-11.
28. Sri V.R, Reddy A. M. A Review On: Cubosomes Drug Delivery System. Indian Journal of Drugs.2017;5(3):104-108.
29. Gaballa S.A.Garhy O.H.Abdelkader H. Cubosomes: Composition, Preparation and Drug Delivery Applications .J.Adv. Biomed and Pharm.Sci.2020;3:1-9.
30. Molly B.A, Prasanthi N.L. Cubic Liquid Crystalline Nanoparticles (Cubosomes):A Novel Carrier for Drug Delivery. Int J of Pharm.Sci.Res.2019;10 (3):973-984.
31. Yalavarthi L.P,Jonnadula P.K . Cubosomes: A Novel Drug Delivery System Overview. Int.J.Res. Ayurveda Pharm.2020;11 (5):198-204.
32. Garg G,Saraf S. Cubosomes: An Overview.Biol.Pharm.Bull.2007;30(2):350-353.
33. Mayuri A,Shipa S.In Vitro and In Vivo Evaluation of Cubosomal In situ Nasal Gel Containing Resveratrol for Brain Targeting.Drug Development and Industrial Pharmacy.2017;43(10):1686-1693.
34. Abdel Bar HM,Basset Sanad RA.Endocytic Pathways of Optimized Resveratrol Cubosomes Capturing into Human Hepatoma Cells. Biomedicines and Pharmacotherapy.2017;93:561-569.
35. Naveentaj S,Muzib Y.I.A Review on Liquid Crystalline Nanoparticles(Cubosomes): Emerging Nanoparticulate Drug Carrier.Int.J Current Pharma.Res.2020;12(1):5-9.
36. Nazaruk E, Majkowska-Pilip A, Bilewicz R. Lipidic Cubic-Phase Nanoparticles— Cubosomes for Efficient Drug Delivery to Cancer Cells. Chempluschem. 2017; 82:570–575.
37. Ali Z, Sharma PK, Warsi MH. Fabrication and evaluation of Ketorolac loaded cubosome for ocular drug delivery. J Appl Pharm Sci. 2016; 6:204–208.
38. Yang Z, Tan Y, Chen M. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability. AAPS PharmSciTech. 2012; 13:1483–1491.
39. Menter MA, See JA, Amend WJC. Proceedings of the psoriasis combination and rotation therapy conference. In:JAAD. 1996; 1:315-321.
40. .Esposito E, Cortesi R, Drechsler M, et al. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. 2005; 22:2163-2173.
41. Han S, Shen JQ, Gan Y. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Acta Pharmacol Sin. 2010; 31:990-998.
42. Ramalheiro A, Paris JL, Silva BFB. Rapidly dissolving microneedles for the delivery of cubosome-like liquid crystalline nanoparticles with sustained release of rapamycin. Int J Pharm. 2020;591:119942

Published

2021-10-15

How to Cite

Chaudhary, K., & Sharma, D. (2021). Cubosomes: A Potential Drug Delivery System. Asian Journal of Pharmaceutical Research and Development, 9(5), 93–101. https://doi.org/10.22270/ajprd.v9i5.981

Issue

Vol. 9 No. 5 (2021): Vol 9 No 5 (2021): Vol 9 No 5 (2021): Volume 9 Issue 5 Set. - Oct. 2021

Section

Review Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).